echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Saisheng Pharmaceutical declares for listing of new antibiotic Tilavacin Hydrochloride for injection

    Saisheng Pharmaceutical declares for listing of new antibiotic Tilavacin Hydrochloride for injection

    • Last Update: 2021-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Author: Shi Bei

    On October 12, the official website of the State Administration of Food and Drug Administration showed that Tilavancin Hydrochloride (former name: Telavancin) for injection by Saisheng Pharmaceutical/Theravance was declared for listing in China


    Telavancin is a lipoglycopeptide antibiotic once a day.


    Tilavancin has a dual antibacterial action mechanism.


    In May 2015, Saisheng Pharmaceutical and Theravance reached an agreement to obtain the exclusive right to develop and commercialize Vibativ in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and Vietnam


    According to the prospectus of Saisheng Pharmaceutical, the market size of anti-MRSA antibacterial drugs in China in 2019 is RMB 4.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.